Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. autart

AutArt

Clinical validation of the AutArt rheumatoid arthritis diagnostic device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 AutArt project word cloud

Explore the words cloud of the AutArt project. It provides you a very rough idea of what is the project "AutArt" about.

deformity    causes    eur    objectivity    rising    destroy    automatically    patients    image    ray    diagnosis    follow    points    sold    disease    2020    diagnostic    sharp    permanently    monitoring    mds    establishment    act    ten    selling    sale    15    2009    companies    rheumatoid    treatments    software    inflammation    validation    bone    scheduled    economic    autoimmune    precise    cartilage    millions    treatment    consists    precision    share    billion    competitors    decreased    provides    scoring    2014    arthritis    people    comparability    union    action    moment    ra    contributes    time    autart    considerably    service    regular    first    feasibility    drugs    line    50    dynamically    diagnoses    progression    lining    sustainability    der    van    device    healthcare    clinical    million    successful    estimate    disabled    biologic    intensive    30    detection    ineffective    causing    chronic    heijde    toolkit    market    serious    25    regulation    health    joints    282    medical    became    evaluation    pharmaceutical    social    modifying    group    sas    agents   

Project "AutArt" data sheet

The following table provides information about the project.

Coordinator		 BIFARMA SZOFTVERFEJLESZTO ES TANACSADO KORLATOLT FELELOSSEGU TARSASAG 

Organization address
address: SZABOLCSKA MIHALY UTCA 1 FSZT 3
city: BUDAPEST
postcode: 1114
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Hungary [HU]
 Project website http://www.bifarma.hu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIFARMA SZOFTVERFEJLESZTO ES TANACSADO KORLATOLT FELELOSSEGU TARSASAG HU (BUDAPEST) coordinator 50˙000.00

Map

 Project objective

The AutArt diagnostic toolkit is a medical device that automatically diagnoses the progression of Rheumatoid Arthritis (RA) on an X-Ray image by using the Sharp/van der Heijde scoring system. This Phase 1 feasibility study will support the clinical validation of the device in Phase 2 that we estimate will cost between 1.5-2 million EUR; with the first market sale scheduled within 2 years, sold SAS (Software as a Service). RA is a chronic autoimmune disease that causes inflammation of the lining of the joints, which can destroy cartilage and bone, causing deformity of the joints. RA is a serious economic and social problem, 20-30% of early RA patients become permanently work disabled during the first 2-3 years of the disease and more than 50% of patients with RA became work disabled during the first ten years of the disease. Classical disease-modifying drugs are ineffective in about 10-15% of the cases, furthermore, biologic agents may also be ineffective. Early detection, regular clinical monitoring and comparable, objective evaluation is essential for successful treatment. The AutArt medical device is the result of 2 years of intensive R&D and at the moment there are no serious competitors in the market, so this is the time to act for a dynamically rising market share in the RA diagnostic market. The target group consists of MDs, medical institutions and pharmaceutical companies. The unique selling points of the product are objectivity, comparability and precision. In the EU, RA treatments cost 25.1 billion EUR in 2009. With more precise diagnosis and objective follow-up this can be decreased considerably with the AutArt medical device. This project is in line with the 282/2014/EU regulation on the establishment of a third Programme for the Union’s action in the field of health (2014-2020) because it contributes to the sustainability of the healthcare system and provides millions of people with better treatment through more precise diagnosis.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AUTART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AUTART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More